Invezz
11 Mar 2026, 10:09 UTC · 27w ago
Verdict
Headline takes no side. We score ORCL +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 76% of ticker scores this week
Its drug Wegovy is seeing stronger early uptake compared to a competitor.
More positive than 70% of ticker scores this week
Earnings are noted as lifting the market rally.
More positive than 70% of ticker scores this week
Benefiting from a lift provided by Intel's earnings.
More positive than 76% of relationship scores this week
[mutual] The article compares Lilly's Foundayo to Novo Nordisk's Wegovy in terms of market uptake.
More positive than 76% of relationship scores this week
[mutual] Nvidia replaced Intel in the Dow and the text discusses their relative market performance and earnings impact.
More positive than 35% of relationship scores this week
[mutual] The article mentions a Google-Anthropic deal.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
4h ago
−3.7%
Price is moving against the score
$143.82 vs $149.40 close before publication (Mar 10) · not market-adjusted
ORCL chart →
